[HTML][HTML] Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma
T Kosaka, Y Yatabe, R Onozato, H Kuwano… - Journal of Thoracic …, 2009 - Elsevier
Introduction: Although mutation of the epidermal growth factor receptor (EGFR) gene is
predictive for the response to EGFR-tyrosine kinase inhibitor, its prognostic impact for …
predictive for the response to EGFR-tyrosine kinase inhibitor, its prognostic impact for …
Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma
YJ Lee, IK Park, MS Park, HJ Choi, BC Cho… - Journal of cancer …, 2009 - Springer
Purpose Although epidermal growth factor receptor (EGFR) tyrosine kinase (TK) mutations
are highly predictive of response to EGFR TK inhibitors in advanced non-small-cell lung …
are highly predictive of response to EGFR TK inhibitors in advanced non-small-cell lung …
Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas
W Liu, L Zhao, Q Pang, Z Yuan, B Li, P Wang - Medical oncology, 2014 - Springer
The purpose of this study was to evaluate the association between epidermal growth factor
receptor (EGFR) mutations and prognosis in patients with completely resected lung …
receptor (EGFR) mutations and prognosis in patients with completely resected lung …
[HTML][HTML] Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma
C Deng, Y Zhang, Z Ma, F Fu, L Deng, Y Li… - The Journal of thoracic …, 2021 - Elsevier
Background Mutation of the EGFR gene is known as a predictor for the response to EGFR
tyrosine kinase inhibitor. Although EGFR mutation status is proposed to be incorporated in …
tyrosine kinase inhibitor. Although EGFR mutation status is proposed to be incorporated in …
Clinical impacts of EGFR mutation status: analysis of 5780 surgically resected lung cancer cases
K Suda, T Mitsudomi, Y Shintani, J Okami, H Ito… - The Annals of thoracic …, 2021 - Elsevier
Background To elucidate the clinical, pathologic, and prognostic impacts of epidermal
growth factor receptor (EGFR) mutation and mutation subtypes in early-stage lung cancer …
growth factor receptor (EGFR) mutation and mutation subtypes in early-stage lung cancer …
[HTML][HTML] Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
JL Marks, S Broderick, Q Zhou, D Chitale, AR Li… - Journal of thoracic …, 2008 - Elsevier
Background Somatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in
lung adenocarcinomas and have potential prognostic value in patients with advanced …
lung adenocarcinomas and have potential prognostic value in patients with advanced …
Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung
Recent studies have reported that clinical response to epidermal growth factor receptor
(EGFR) inhibitors is associated with somatic changes of EGFR in the advanced stage of lung …
(EGFR) inhibitors is associated with somatic changes of EGFR in the advanced stage of lung …
Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma
M Yotsukura, H Yasuda, T Shigenobu, K Kaseda… - Lung Cancer, 2017 - Elsevier
Objectives Over the past decade, the biological and clinical characteristics of lung cancer
with epidermal growth factor receptor (EGFR) mutation have been well studied. However …
with epidermal growth factor receptor (EGFR) mutation have been well studied. However …
[HTML][HTML] Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib
Background: EGFR and KRAS mutations are mutually exclusive and predict outcomes with
epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment in patients …
epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment in patients …
[HTML][HTML] The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non–small-cell …
YT Kim, YW Seong, YJ Jung, YK Jeon, IK Park… - Journal of Thoracic …, 2013 - Elsevier
Background The presence of mutation in EGFR gene is known as a predictive marker for the
response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) …
response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) …
相关搜索
- surgically treated lung adenocarcinoma
- tp53 gene mutations
- lung adenocarcinoma large cohort
- lung adenocarcinoma japanese patients
- lung adenocarcinoma prognostic implication
- lung adenocarcinoma prognostic impacts
- lung adenocarcinoma kras mutations
- growth factor lung adenocarcinomas
- prognostic factor lung cancer
- receptor mutations lung adenocarcinomas
- presence of mutations lung cancer
- resected lung adenocarcinoma
- lung adenocarcinoma subtype in patients
- prognostic value lung adenocarcinomas
- lung cancer cases
- small cell lung cancer